XML 18 R9.htm IDEA: XBRL DOCUMENT v3.23.3
Fair Value of Financial Instruments
9 Months Ended
Sep. 30, 2023
Fair Value Disclosures [Abstract]  
Fair Value of Financial Instruments

4. Fair Value of Financial Instruments

The following tables summarize the fair value of the Company’s financial instruments (in thousands):

 

 

 

 

 

 

Fair Value Measurements Using

 

 

 

September 30,
2023

 

 

Quoted Prices
in Active
Markets for
Identical Assets
(Level 1)

 

 

Significant
Other
Observable
Inputs
(Level 2)

 

 

Significant
Unobservable
Inputs
(Level 3)

 

Assets:

 

 

 

 

 

 

 

 

 

 

 

 

Cash equivalents:

 

 

 

 

 

 

 

 

 

 

 

 

Money market funds

 

$

17,437

 

 

$

17,437

 

 

$

 

 

$

 

Short-term investments:

 

 

 

 

 

 

 

 

 

 

 

 

Corporate debt securities

 

$

47,423

 

 

$

 

 

$

47,423

 

 

$

 

Commercial paper

 

 

37,546

 

 

 

 

 

 

37,546

 

 

 

 

U.S. Government securities

 

 

152,382

 

 

 

 

 

 

152,382

 

 

 

 

Total short-term investments

 

 

237,351

 

 

 

 

 

 

237,351

 

 

 

 

Total

 

$

254,788

 

 

$

17,437

 

 

$

237,351

 

 

$

 

 

 

 

 

 

 

Fair Value Measurements Using

 

 

 

December 31,
2022

 

 

Quoted Prices
in Active
Markets for
Identical Assets
(Level 1)

 

 

Significant
Other
Observable
Inputs
(Level 2)

 

 

Significant
Unobservable
Inputs
(Level 3)

 

Assets:

 

 

 

 

 

 

 

 

 

 

 

 

Cash equivalents:

 

 

 

 

 

 

 

 

 

 

 

 

Money market funds

 

$

36,494

 

 

$

36,494

 

 

$

 

 

$

 

Short-term investments:

 

 

 

 

 

 

 

 

 

 

 

 

Corporate debt securities

 

$

88,681

 

 

$

 

 

$

88,681

 

 

$

 

Commercial paper

 

 

65,409

 

 

 

 

 

 

65,409

 

 

 

 

Government securities

 

 

160,559

 

 

 

 

 

 

160,559

 

 

 

 

Total short-term investments

 

 

314,649

 

 

 

 

 

 

314,649

 

 

 

 

Total

 

$

351,143

 

 

$

36,494

 

 

$

314,649

 

 

$

 

Cash Equivalents and Investments

Financial assets measured at fair value on a recurring basis consist of the Company’s cash equivalents and short-term and long-term investments. Cash equivalents consisted of money market funds and short-term and long-term investments consisted of commercial paper, government securities and corporate bonds. The Company obtains pricing information from its investment manager and generally determines the fair value of investment securities using standard observable inputs, including reported trades, broker/dealer quotes, and bids and/or offers.

Investments are classified as Level 1 within the fair value hierarchy if their quoted prices are available in active markets for identical securities. Investments in money market funds of $17.4 million and $36.5 million as of September 30, 2023 and December 31, 2022, respectively, were classified as Level 1 instruments and were included in cash and cash equivalents.

Investments in marketable securities are valued using Level 2 inputs. Level 2 securities are initially valued at the transaction price and subsequently valued and reported upon utilizing inputs other than quoted prices that are observable either directly or indirectly, such as quotes from third-party pricing vendors. Fair values determined by Level 2 inputs, which utilize data points that are observable such as quoted prices, interest rates and yield curves, require the exercise of judgment and use of estimates, that if changed, could significantly affect the Company’s financial position and results of operations. The marketable securities of $237.4 million and $314.6 million as of September 30, 2023 and December 31, 2022, respectively, were classified as Level 2 instruments and included in short-term investments. Accrued interest receivable related to investments was $0.9 million and $0.8 million as of September 30, 2023 and December 31, 2022, respectively, and included as part of prepaid expenses and other current assets in the condensed balance sheets.

The following tables summarize the Company’s investments accounted for as available-for-sale securities as of September 30, 2023 and December 31, 2022 (in thousands):

 

 

 

 

 

September 30, 2023

 

 

 

Maturity
(in years)

 

Amortized
Cost

 

 

Unrealized
Losses

 

 

Unrealized
Gains

 

 

Estimated
Fair Value

 

Corporate debt securities

 

1 year or less

 

$

47,507

 

 

$

(84

)

 

$

 

 

$

47,423

 

Commercial paper

 

1 year or less

 

 

37,663

 

 

 

(117

)

 

 

 

 

 

37,546

 

U.S. Government securities

 

1 year or less

 

 

152,590

 

 

 

(210

)

 

 

2

 

 

 

152,382

 

Total

 

 

 

$

237,760

 

 

$

(411

)

 

$

2

 

 

$

237,351

 

 

 

 

 

 

December 31, 2022

 

 

 

Maturity
(in years)

 

Amortized
Cost

 

 

Unrealized
Losses

 

 

Unrealized
Gains

 

 

Estimated
Fair Value

 

Corporate debt securities

 

1 year or less

 

$

88,995

 

 

$

(320

)

 

$

6

 

 

$

88,681

 

Commercial paper

 

1 year or less

 

 

65,532

 

 

 

(123

)

 

 

 

 

 

65,409

 

Government securities

 

1 year or less

 

 

160,801

 

 

 

(319

)

 

 

77

 

 

 

160,559

 

Total

 

 

 

$

315,328

 

 

$

(762

)

 

$

83

 

 

$

314,649

 

 

The Company has classified its investment securities as current and non-current assets on the condensed balance sheets based on each security's contractual maturity date, and all investment securities are accounted for as available-for-sale because these investment securities are considered available for use in current operations.

The Company considers whether unrealized losses have resulted from a credit loss or other factors. The unrealized losses on the Company’s available-for-sale securities as of September 30, 2023 and December 31, 2022 were caused by fluctuations in market value and interest rates as a result of the economic environment and not credit risk. The Company concluded that an allowance for credit losses was unnecessary as of September 30, 2023 and December 31, 2022. It is neither management’s intention to sell nor is it more likely than not that the Company will be required to sell these investments prior to recovery of their cost basis or recovery of fair value. Unrealized gains and losses are included in accumulated other comprehensive loss.

During the nine months ended September 30, 2023, there were immaterial realized gains recognized on available-for-sale securities sold in the period. There was no realized gain or loss on available-for-sale securities for the nine months ended September 30, 2022. The Company uses the specific identification method to determine the cost basis of investments sold.